2025-2021

Evido Health

Evido is founded and anchored in state-of-the-art clinical research where the suffering from untimely diagnosis of chronic liver disease sparked the urge to do more.

Spin-out in 2022

Inverna Therapeutics

Inverna Therapeutics develops an RNA therapeutics platform to modify RNA expression with unparalleled specificity. Leveraging sequence-specific activation of pseudo exons, we develop safer, more effective precision medicines for unmet medical needs.

Spin-out in 2024

Mion Technology ApS

We are developing a flexible and functional anti-microbial anodizering for use on various metal surfaces. Which prevents bacterial biofilm formation, and thus to provide an antimicrobial technology to manufacturers worldwide.

Spin-out in 2021

Nordic Microbes

Nordic Microbes (Bioomix) develops microbial solutions for farmers. Our products are able to replace agrochemicals and synthetic fertilizer, but at the same time maintain crop production levels.

Spin-out in 2021

OncoSpear ApS 

Spin-out in 2021

Praemonsto

Praemostro originated from a research project at Odense University Hospital. Today, we are an independent company helping you optimize resources and create a more stable daily workflow.

Spin-out in 2024

Simulated Design ApS

Simulated Designs ApS specializes in designing and producing vibratory feeder bowls using Dynamic Simulation and 3D printing. This accelerates the designing process from traditionally taking weeks or even months to now only days.

Spin-out in 2021

Theta Optical Technologies

Spin-out in 2023